The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Restenosis is a complex disease for which the pathophysiological mechanisms have not yet
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …

Background—Sustained benefits of drug-eluting stents in femoropopliteal arteries have not
been demonstrated. This prospective, multinational, randomized study was designed to …

Background Coronary stents improve immediate and late results of balloon angioplasty by
tacking up dissections and preventing wall recoil. These goals are achieved within weeks …

ContextCompared with bare metal stents, sirolimus-eluting and paclitaxel-eluting stents
have been shown to markedly improve angiographic and clinical outcomes after …

Objectives: This study aimed to evaluate the degradation rate and long-term vascular
responses to the absorbable metal stent (AMS). Background: The AMS demonstrated …

Objectives: The aim of this study was to examine the 5-year clinical safety and efficacy
outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native …

Objectives: This study examined the clinical outcomes at 5 years in RAVEL (A Randomized
Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary …

The release of sirolimus from a bi-layer biodegradable polymeric film is reported in this
study. Approved drug-eluting metal stents use a thin polymer coating to control drug release …

Objectives: We sought to identify the frequency of incomplete stent apposition (ISA) in
sirolimus-eluting stents (SES) and clarify its findings and clinical sequelae. Background …